Safety and Efficacy of Individual Batches of ATG-F in Kidney Transplant Recipients: Multicentre, Prospective, Observational Study
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 19 Jan 2018
At a glance
- Drugs Antithymocyte globulin (Primary)
- Indications Renal transplant rejection
- Focus Adverse reactions
- Sponsors Astellas Pharma
- 15 Jan 2018 Status changed from recruiting to active, no longer recruiting.
- 10 Jan 2018 Planned End Date changed from 31 Mar 2018 to 1 Mar 2018.
- 10 Jan 2018 Planned primary completion date changed from 31 Mar 2018 to 1 Mar 2018.